These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

816 related articles for article (PubMed ID: 31617564)

  • 1. Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors.
    Lange M; Joly F; Vardy J; Ahles T; Dubois M; Tron L; Winocur G; De Ruiter MB; Castel H
    Ann Oncol; 2019 Dec; 30(12):1925-1940. PubMed ID: 31617564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-Related Cognitive Impairment Associated with APOE rs7412 and BDNF rs6265 in Breast Cancer Survivors.
    Hsiao CP; Goto T; Von Ah D; Saligan LN
    Semin Oncol Nurs; 2024 Oct; 40(5):151721. PubMed ID: 39198096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-related cognitive impairment: updates to treatment, the need for more evidence, and impact on quality of life-a narrative review.
    Yang Y; Von Ah D
    Ann Palliat Med; 2024 Sep; 13(5):1265-1280. PubMed ID: 39260437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catechol-O-Methyltransferase Gene Polymorphisms and the Risk of Chemotherapy-Induced Prospective Memory Impairment in Breast Cancer Patients with Varying Tumor Hormonal Receptor Expression.
    Li W; Zhao J; Ding K; Chao HH; Li CR; Cheng H; Shen L
    Med Sci Monit; 2020 Sep; 26():e923567. PubMed ID: 32985495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy-related cognitive impairment: mechanisms, clinical features and research perspectives.
    Cascella M; Di Napoli R; Carbone D; Cuomo GF; Bimonte S; Muzio MR
    Recenti Prog Med; 2018 Nov; 109(11):523-530. PubMed ID: 30565571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replication and Meta-analysis of the Association between BDNF Val66Met Polymorphism and Cognitive Impairment in Patients Receiving Chemotherapy.
    Tan CJ; Lim SWT; Toh YL; Ng T; Yeo A; Shwe M; Foo KM; Chu P; Jain A; Koo SL; Dent RA; Ng RCH; Yap YS; Lim EH; Loh KW; Chay WY; Lee GE; Tan TJY; Beh SY; Wong M; Chan JJ; Khor CC; Ho HK; Chan A
    Mol Neurobiol; 2019 Jul; 56(7):4741-4750. PubMed ID: 30382534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy-induced cognitive impairment in breast cancer survivors: A systematic review of studies from 2000 to 2021.
    Amani O; Mazaheri MA; Moghani MM; Zarani F; Choolabi RH
    Cancer Rep (Hoboken); 2024 Feb; 7(2):e1989. PubMed ID: 38351543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic risk factors for cancer-related cognitive impairment: a systematic review.
    Buskbjerg CDR; Amidi A; Demontis D; Nissen ER; Zachariae R
    Acta Oncol; 2019 May; 58(5):537-547. PubMed ID: 30822178
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemotherapy-related cognitive impairment in older patients with cancer.
    Loh KP; Janelsins MC; Mohile SG; Holmes HM; Hsu T; Inouye SK; Karuturi MS; Kimmick GG; Lichtman SM; Magnuson A; Whitehead MI; Wong ML; Ahles TA
    J Geriatr Oncol; 2016 Jul; 7(4):270-80. PubMed ID: 27197918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of brain-derived neurotrophic factor rs6265 polymorphism and cognitive function in breast cancer survivors from a cross-sectional study.
    Goto T; Saligan LN; Li X; Xiang L; Kwiat C; Nguyen C; Crouch A; Von Ah D
    Cancer Med; 2024 Jan; 13(2):e6975. PubMed ID: 38379321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of plasma brain-derived neurotrophic factor (BDNF) and Val66Met polymorphism (rs6265) with long-term cancer-related cognitive impairment in survivors of breast cancer.
    Yap NY; Tan NYT; Tan CJ; Loh KW; Ng RCH; Ho HK; Chan A
    Breast Cancer Res Treat; 2020 Oct; 183(3):683-696. PubMed ID: 32696315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of common genetic variants in cognitive decline in the first seven years of Parkinson's disease: A longitudinal observational study.
    Chung J; Ushakova A; Doitsidou M; Tzoulis C; Tysnes OB; Dalen I; Pedersen KF; Alves G; Maple-Grødem J
    Neurosci Lett; 2021 Nov; 764():136243. PubMed ID: 34509566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer plus adjuvant chemotherapy- related cognitive impairment: a case study.
    Fischer B
    Neurocase; 2019; 25(3-4):138-144. PubMed ID: 31237172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-related cognitive impairment in children.
    Hutchinson AD; Pfeiffer SM; Wilson C
    Curr Opin Support Palliat Care; 2017 Mar; 11(1):70-75. PubMed ID: 28009650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Experience of Cancer-Related Cognitive Impairment Across Common Cancers: Protocol for a Qualitative Systematic Review.
    Ibrar M; Rai HK; Main A; McCartney H; Maguire R; Rodriguez MAP
    JMIR Res Protoc; 2024 May; 13():e56888. PubMed ID: 38820581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Acupuncture on Cancer-Related Cognitive Impairment in Chinese Gynecological Cancer Patients: A Pilot Cohort Study.
    Zeng Y; Cheng ASK; Song T; Sheng X; Wang S; Xie J; Chan CCH
    Integr Cancer Ther; 2018 Sep; 17(3):737-746. PubMed ID: 29806502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms and Treatment for Cancer- and Chemotherapy-Related Cognitive Impairment in Survivors of Non-CNS Malignancies.
    Chung NC; Walker AK; Dhillon HM; Vardy JL
    Oncology (Williston Park); 2018 Dec; 32(12):591-8. PubMed ID: 30632128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BDNF Augmentation Using Riluzole Reverses Doxorubicin-Induced Decline in Cognitive Function and Neurogenesis.
    Usmani MT; Krattli RP; El-Khatib SM; Le ACD; Smith SM; Baulch JE; Ng DQ; Acharya MM; Chan A
    Neurotherapeutics; 2023 Apr; 20(3):838-852. PubMed ID: 36720792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive impairment following chemotherapy for breast cancer: The impact of practice effect on results.
    Cerulla N; Arcusa À; Navarro JB; de la Osa N; Garolera M; Enero C; Chico G; Fernández-Morales L
    J Clin Exp Neuropsychol; 2019 Apr; 41(3):290-299. PubMed ID: 30477390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive complications of cancer and cancer-related treatments - Novel paradigms.
    Lomeli N; Lepe J; Gupta K; Bota DA
    Neurosci Lett; 2021 Apr; 749():135720. PubMed ID: 33582187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.